Development of the selective progesterone receptor modulator CDB-2914 for clinical indications
article
OA: closed
CC0
⤵ 10 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper describes the development of CDB-2914, a selective progesterone receptor modulator, for potential clinical applications.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (16)
- Dating the Endometrial Biopsy via openalex
- Effect of long-term treatment with low-dose mifepristone on the endometrium via openalex
- W2016301974 via openalex
- W2025259495 via openalex
- W2045180596 via openalex
- W2047844288 via openalex
- W2087289721 via openalex
- W2089667775 via openalex
- W2093512443 via openalex
- W2096483577 via openalex
- W2102218899 via openalex
- W2104079818 via openalex
- W2105809134 via openalex
- W2246590518 via openalex
- W2729599081 via openalex
- W1910306760 via openalex
Cited by (10)
- Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens 2022
- Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids 2022
- Novel pharmacological therapies for the treatment of endometriosis 2022
- Selective Progesterone Receptor Modulators (SPRMs) and Androgen Receptor Modulators (SARMs) as Treatment for Benign Gynecologic Diseases 2021
- Hepatotoxizität selektiver Progesteronrezeptormodulatoren 2021
- Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone 2017
- Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues 2014
- Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques 2009
- Selective progesterone receptor modulators 2: use in reproductive medicine 2008
- Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications 2005
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK